Survey-based identification of design requirements and constraints for a wearable tremor suppression device
- PMID: 35548101
- PMCID: PMC9083043
- DOI: 10.1177/20556683221094480
Survey-based identification of design requirements and constraints for a wearable tremor suppression device
Abstract
Introduction: Parkinsonian tremor has severely impacted the lives of 65% of individuals with Parkinson's disease, and nearly 25% do not respond to traditional treatments. Although wearable tremor suppression devices (WTSDs) have become a promising alternative approach, this technology is still in the early stages of development, and no studies have reported the stakeholders' opinions on this technology and their desired design requirements.
Methods: An online survey was distributed to affected Canadians and Canadian movement disorder specialists (MDS) to acquire information on demographics, the current state of treatments, opinions on the WTSDs, and the desired design requirements of future WTSDs.
Results: A total of 101 affected individuals and 24 MDS completed the survey. It was found that both groups are generally open to using WTSDs to manage tremor. The most important design requirement to end users is the adaptability to lifestyle, followed by weight and size, accurate motion, comfort, safety, quick response, and cost. Lastly, most of the participants (65%) think that the device should cost under $500.
Conclusions: The findings from this study can be used as guidelines for the development of future WTSDs, such that the future generations could be evaluated and accepted by the end users.
Keywords: Parkinson’s disease; Wearable tremor suppression device; design requirements; medical informatics; movement disorder; survey.
© The Author(s) 2022.
Conflict of interest statement
Declaration of conflicting interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Public Health Agency of Canada . Parkinsonism in Canada, including Parkinson’s disease, 2019. Ottawa, ON: Public Health Agency Of Canada, https://www.canada.ca/en/public-health/services/publications/diseases-co...
-
- Gaskin J, Gomes J, Darshan S, et al. Burden of neurological conditions in Canada. Neurotoxicology 2017; 61: 2–10. - PubMed
-
- Fredericks D, Norton JC, Atchison C, et al. Parkinson’s disease and Parkinson’s disease psychosis: a perspective on the challenges, treatments, and economic burden. The Am J Managed Care 2017; 23: S83–S92. - PubMed
-
- Chaudhuri KR, Titova N. Societal burden and persisting unmet needs of Parkinson’s disease. European Neurological Review 2019; 14(1): 28–35.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
